Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

Completed · Not applicable

Conditions studied: Chronic Subdural Hematoma

In brief

This is a prospective, multi-center, open-label, randomized controlled study in which subjects can receive standard of care (SOC) alone or SOC and TRUFILL n-BCA MMA embolization for the treatment of chronic subdural hematomas (cSDH).

Key facts

Study ID
NCT04816591
Run by
Cerenovus, Part of DePuy Synthes Products, Inc.
People needed
376
Starts
2021-05-27
Expected to finish
2025-03-26
Last updated by the study team
2026-07-06

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.